Could Viking Therapeutics Stock Be a Millionaire Maker?
There aren't many hotter stocks on the market right now than Viking Therapeutics (NASDAQ: VKTX). Shares of the biopharmaceutical company have skyrocketed around 340% so far this year.
However, those impressive gains might be just a start for Viking. The company should have plenty of potential catalysts over the next few years. Could Viking Therapeutics stock be a millionaire-maker?
Investors' excitement about Viking Therapeutics reached a fever pitch on Feb. 27, 2024, when the company announced the results from a phase 2 clinical study evaluating VK2735 in patients with obesity. Viking reported its experimental drug helped patients achieve a placebo-adjusted mean weight loss of up to 13.1% after 13 weeks of treatment. This reflected faster weight loss than Novo Nordisk's Wegovy and Ei Lilly's Zepbound achieved in their clinical trials.
Source Fool.com
Viking Therapeutics Inc Aktie
Viking Therapeutics Inc erfreut sich mäßiger Beliebtheit, mit mehr Buy- als Sell-Einschätzungen.
Für Viking Therapeutics Inc ergibt sich mit einem Kursziel von 110 € eine mögliche Steigerung von über 50% gegenüber 56.72 €.
